13.40
+1.9(+16.52%)
Currency In GBp
Address
32-33 Cowcross Street
London, EC1M 6DF
United Kingdom of Great Britain and Northern Ireland
Phone
44 20 3150 0252
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
27
First IPO Date
March 31, 2022
| Name | Title | Pay | Year Born |
| Mr. James Gareth Short | Co-Founder, Chief Executive Officer & Executive Director | 245,000 | 1968 |
| Mr. Paul Allen | Co-Founder | 0 | N/A |
| Iqbal Gill | Chief Scientific Officer | 0 | N/A |
| Ms. Kerin Williams | Company Secretary | 0 | 1970 |
Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.
